Showing results (141-150 of 181) with videos related to
Sort By:
Pageof 19
Advances in Radiation Oncology|November 9, 2017
Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort studyAnhui Shi, Zhongxing Liao, Pamela K Allen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2015
Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancerQuynh-Nhu Nguyen, Ngoc Bui Ly, Ritsuko Komaki, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 5, 2013
Aortic dose constraints when reirradiating thoracic tumorsJaden D Evans, Daniel R Gomez, Arya Amini, et al.International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and IIJeff M Michalski, Kathryn Winter, James A Purdy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neckNaomi R Schechter, Richard E Wendt, David J Yang, et al.International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric studyJames Welsh, Daniel Gomez, Matthew B Palmer, et al.Molecular Endocrinology (Baltimore, Md.)|August 29, 2002
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary glandCelina M D'Cruz, Susan E Moody, Stephen R Master, et al.Practical Radiation Oncology|November 20, 2014
Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical settingLaleh Kardar, Yupeng Li, Xiaoqiang Li, et al.Medical Physics|February 11, 2014
On the interplay effects with proton scanning beams in stage III lung cancerYupeng Li, Laleh Kardar, Xiaoqiang Li, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2017
Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancerJoe Y Chang, Wencheng Zhang, Ritsuko Komaki, et al.Pageof 19